| HOME >> BIOLOGY >> TECHNOLOGY |
Deferred tax assets 1,180,199 579,703
Total current assets 57,270,560 39,181,889
Restricted cash 448,532 846
Property, plant and equipment 18,811,886 15,879,391
Long-term prepaid expenses and
deposits 282,767 298,731
Deferred tax asset 989,990 693,053
Licenses and permits 1,285,732 1,394,052
Total assets $ 79,089,467 $ 57,447,962
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Loans payable $ 7,276,114 $ 6,836,110
Accounts payable and accrued
liabilities 13,929,071 9,522,818
Due to related parties 46,971 46,971
Dividends payable to minority
interest shareholder
of Sinovac Beijing 115,380 3,000,458
Deferred research grants 1,060,782 1,038,396
Total current liabilities 22,428,318 20,447,754
Deferred government grants 2,910,446 2,734,444
Loan payable 1,455,223 1,367,222
Long - term debt 4,365,669 4,101,666
Total liabilities 26,793,987 24,546,420
Minority interest 5,264,385 2,897,687
Commitments and contingencies
STOCKHOLDERS' EQUITY
Preferred stock -- --
Authorized 50,000,000 shares at par
value of $0.001 each
'/>"/>| SOURCE Sinovac Biotech Ltd. Copyright©2008 PR Newswire. All rights reserved |